Kemadrin

Procyclidine, the active ingredient in Kemadrin, is an anticholinergic (muscarinic antagonist) presented as a tablet for oral use. It treats Parkinson's disease symptoms such as tremor and rigidity, and drug‑induced extrapyramidal symptoms in adults.

GNH USA supplies Kemadrin as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Procyclidine is used in the management of movement disorders that involve excessive cholinergic activity.

- Parkinson's disease (tremor, rigidity): reduces motor symptoms and improves daily function. - Drug‑induced extrapyramidal symptoms: alleviates dystonia, akathisia and other drug‑related movement disorders. - Secondary Parkinsonian syndrome: helps control motor disturbances when Parkinsonism arises from other causes.

Procyclidine may cause a range of anticholinergic‑related adverse reactions.

Common Side Effects: - Dry mouth - Blurred vision - Constipation - Urinary retention - Dizziness - Nausea

Serious or Rare Side Effects: - Confusion or hallucinations - Severe tachycardia - Allergic reactions such as rash or angioedema - Neuroleptic malignant syndrome (very rare) - Acute glaucoma exacerbation

When prescribing Procyclidine, consider the following safety measures.

- Renal impairment: assess kidney function and adjust dose if necessary. - Elderly patients: monitor for increased anticholinergic burden and cognitive effects. - History of glaucoma: avoid or use with extreme caution. - Cardiac disease: watch for tachycardia or arrhythmias. - Pregnancy: safety unknown; avoid unless benefits outweigh risks. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Procyclidine can interact with several medication classes; awareness helps prevent additive effects.

Major Interactions (Avoid): - Antihistamines (e.g., diphenhydramine): additive anticholinergic effects. - Tricyclic antidepressants: increased anticholinergic load. - Antipsychotics (e.g., haloperidol): may worsen extrapyramidal symptoms. - Beta‑blockers: may mask tachycardia. - Opioids: enhanced constipation risk.

Moderate Interactions (Monitor Closely): - Alzheimer’s drugs (e.g., donepezil): opposite mechanisms may reduce efficacy. - Antihypertensives: may increase orthostatic hypotension. - Diuretics: heightened risk of urinary retention.